Longitudinal progression trajectory of GFR among patients with CKD.
暂无分享,去创建一个
Liang Li | Tom H Greene | Bo Hu | Lawrence J Appel | Brad C Astor | B. Astor | L. Appel | J. Lewis | T. Greene | R. Toto | Xuelei Wang | Liang Li | Bo Hu | Julia Lewis | Michael S Lipkowitz | Robert D Toto | Xuelei Wang | Jackson T Wright | M. Lipkowitz | J. Wright
[1] J. Lewis,et al. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] M. Kutner,et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). , 2003, Journal of the American Society of Nephrology : JASN.
[3] N W Shock,et al. Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.
[4] G. Beck,et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.
[5] Black Mm. Letter: Cryostat sections in immunological studies of cancer. , 1973 .
[6] G. Beck,et al. The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .
[7] N. Madias,et al. Serum creatinine and renal function. , 1988, Annual review of medicine.
[8] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] Teven,et al. EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .
[10] Keith C. Norris,et al. The rationale and design of the AASK cohort study. , 2003, Journal of the American Society of Nephrology : JASN.
[11] W. Mitch,et al. A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.
[12] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[13] R. Garrick. Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease , 2008 .
[14] Ciprian M. Crainiceanu,et al. Bayesian Analysis for Penalized Spline Regression Using WinBUGS , 2005 .
[15] Tom Greene,et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.